Fibrinolytic treatment in primary antiphospholipid syndrome

Lupus

Volumn 5, Issue 6, 1996, Pages 627-629

  Camps Garcia M T ^a,b   Guil, M ^a   Sanchez Lora, J ^a   Grana, M I ^a   Martinez J ^a   De Ramon E ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b Urbanización El Lagar   (Spain)

Author keywords

Fibrinolytics; Primary antiphospholipid syndrome; Urokinase

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; PHOSPHOLIPID ANTIBODY; UROKINASE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CAVA VEIN; FEMORAL VEIN; FIBRINOLYTIC THERAPY; HUMAN; ILIAC VEIN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; VEIN THROMBOSIS;

EID: 0030473561     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500613     Document Type: Article

References (12)

1. Harris EN. Syndrome of the black swan Br J Rheumatol 1987; 26: 324-326
2. Love PE, Santoro SA. Antiphosphohpid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders, prevalence and clinical significance. Ann Intern Med 1990; 112: 682-698.
3. Alarcón-Segovia D et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-365.
4. Vivancos J et al. Sindrome antifosfolípido primario: estudio clínico y biologico de 36 casos Med Clin (Barc) 1994, 15. 561-565
5. Hughes GRV The antiphospholipid syndrome: ten years ago. Lancet 1993; 342: 341-344
6. Lockshin MD Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 1993; 19: 235-247.
7. Levine SR, Brey RL, Joseph CLM, Havstad S. Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 1992; 23(suppl 1): I-29-I-32.
8. Khamashta MA et al. The management of thrombosis in the antiphospholipid syndrome N Engl J Med 1995; : 993-997
9. Derksen RHWM, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive life-long anticoagulant treatment. Ann Rheum Dis 1993; 52: 689-692.
10. Khamashta MA, Wallington T. Management of the antiphospholipid syndrome. Ann Rheum Dis 1991; 50: 959-962.
11. Handin RI. Anticoagulant, fibrinotytic, and antiplatelet therapy. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds). Harrison's Principles of Internal Medicine. 13th ed. Vol. 2. New York, McGraw-Hill, 1994; 1810-1813.
12. Lockshin MD. Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994; 20: 45-59.